Founder Aaron Rollins reports 23.6% Airsculpt (AIRS) stake and weighs options

Rhea-AI Filing Summary

Aaron Rollins filed a Schedule 13D reporting beneficial ownership of 14,721,062 shares of Airsculpt Technologies, Inc., representing 23.6% of its common stock. He holds sole voting and dispositive power over these shares, reflecting his role as founder and former CEO and Executive Chairman.

Rollins states that his stake comes from equity compensation for his executive roles and from personal open-market purchases, including 152,118 shares bought for about $473,837.49, excluding commissions. He is actively evaluating strategic alternatives for his investment, which may include buying more shares, selling shares, seeking board representation, proposing strategic or change-of-control transactions, or advocating changes to strategy, governance, management, or capital allocation. He has not traded in the past 60 days and notes no contracts or arrangements relating to the issuer’s securities.

Insights

Equity ownership and activism analyst

Founder discloses a 23.6% stake and signals potential activism.

The filing shows Aaron Rollins beneficially owns 14,721,062 shares of Airsculpt Technologies, Inc., equal to 23.6% of the common stock, with sole voting and dispositive power. This consolidates significant influence in the hands of the company’s founder and former CEO and Executive Chairman.

Rollins acquired most shares through his executive roles, plus 152,118 shares bought in the open market for about $473,837.49. He is “actively evaluating a wide range of strategic alternatives,” listing possibilities from further share purchases or sales to seeking board representation, pushing strategic or change-of-control transactions, and advocating changes in governance or capital allocation.

The language mirrors an activist-style framework, signaling flexibility rather than a specific plan. There have been no trades in the past 60 days, so any impact will depend on future actions he chooses from this broad menu of options, as described in Item 4.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Airsculpt Technologies, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

009496100

(CUSIP Number)

Aaron Rollins
570 Lake Cook Road, Suite 320,
Deerfield, IL, 60015
(312) 961-7612

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

03/13/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 009496100

1

Name of reporting person

Rollins Aaron

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 14,721,062.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 14,721,062.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

14,721,062.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

23.6 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.001 par value per share
(b)	Name of Issuer: Airsculpt Technologies, Inc.
(c)	Address of Issuer's Principal Executive Offices: 1111 LINCOLN ROAD, SUITE 802, MIAMI BEACH, FLORIDA , 33139.
Item 2.	Identity and Background
(a)	This Schedule 13D is filed by Aaron Rollings (the "Reporting Person").
(b)	The principal business address of the Reporting Person is 570 Lake Cook Road, Suite 320, Deerfield, Illinois 60015.
(c)	The principal business of the Reporting Person is working as a cosmetic surgeon.
(d)	During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations of similar misdemeanors).
(e)	During the last five years, the Reporting Person has not been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	The Reporting Person is a citizen of the United States.
Item 3.	Source and Amount of Funds or Other Consideration
	The shares covered by this Schedule 13D are solely owned by the Reporting Person and were acquired in consideration of his services as Chief Executive Officer and as Executive Chairman of the Board and using personal funds in open market purchases. The aggregate purchase price of the 152,118 shares beneficially owned by the Reporting Person purchased in open market purchases is approximately $473,837.49, excluding brokerage commissions.
Item 4.	Purpose of Transaction
	The Reporting Person is the Issuer's founder and previously served as Chief Executive Officer from 2012 to 2023 and as Executive Chairman of the Board from 2023 to 2025. The Reporting Person acquired shares of Common Stock of the Issuer, which represent 23.6% of the Issuer's outstanding Common Stock, through his employment with the Company and using personal funds. The Reporting Person is actively evaluating a wide range of strategic alternatives with respect to his investment in the Issuer. Depending on various factors including the Issuer's financial and operating performance, industry conditions, market prices of the Shares, general economic and market conditions, regulatory and legal considerations and other relevant factors the Reporting Person may, at any time and from time to time, determine to take such actions as he considers advisable in furtherance of his investment objectives. Such actions may include, without limitation: (i) acquiring additional shares of Common Stock or other securities of the Issuer (including through open-market purchases, privately negotiated transactions, or derivative or other instruments); (ii) disposing of some or all of its holdings; (iii) seeking representation on the Issuer's board of directors, which may include engaging in discussions with the Issuer regarding board composition, proposing or nominating director candidates, and/or soliciting proxies or consents in support of such nominees or other proposals, as permitted by law; (iv) proposing, evaluating, or engaging in discussions regarding strategic alternatives, extraordinary corporate transactions, or potential business combination or change-of-control transactions involving the Issuer; (v) proposing or advocating changes to the Issuer's strategy, operations, capital allocation, governance, management, or corporate structure; (vi) engaging with third parties (including other stockholders, potential partners, financing sources, or counterparties) regarding any of the foregoing; (vii) requesting that the Issuer call a special meeting of stockholders or taking action by written consent to the extent permitted by the Issuer's governing documents and applicable law; and (viii) entering into customary confidentiality, engagement, advisory, financing, swap, derivative, or other arrangements in connection with evaluating or pursuing any of the foregoing. The Reporting Person intends to review his investment in the Issuer on an ongoing basis and may formulate, revise, or withdraw plans and proposals at any time.
Item 5.	Interest in Securities of the Issuer
(a)	The information set forth in Items 3 and 4 of this Schedule 13D is incorporated by reference into this Item 5. See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Common Stock and percentage of the Common Stock beneficially owned by the Reporting Person.
(b)	See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Common Stock to which the Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
(c)	During the past 60 days, the Reporting Person has not effected any transaction with respect to the Issuer's Common Stock.
(d)	Not applicable.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Rollins Aaron

Signature:	/s/ Aaron Rollings
Name/Title:	Aaron Rollins
Date:	03/13/2026

FAQ

How large is Aaron Rollins’ stake in Airsculpt Technologies (AIRS)?

Aaron Rollins reports beneficial ownership of 14,721,062 shares of Airsculpt Technologies, Inc., representing 23.6% of the company’s common stock. He has sole voting and sole dispositive power over all of these shares, giving him substantial influence as a major shareholder and founder.

How did Aaron Rollins acquire his Airsculpt Technologies (AIRS) shares?

Aaron Rollins’ shares were acquired as consideration for his services as Chief Executive Officer and Executive Chairman and through personal open-market purchases. He bought 152,118 shares in the open market for about $473,837.49, excluding brokerage commissions, in addition to equity received from his executive roles.

What intentions does Aaron Rollins state for his Airsculpt Technologies (AIRS) investment?

Aaron Rollins says he is actively evaluating strategic alternatives for his Airsculpt stake. Possible actions include buying more shares, selling shares, seeking board representation, proposing strategic or change-of-control transactions, and advocating changes to strategy, governance, management, capital allocation, or corporate structure.

Has Aaron Rollins traded Airsculpt Technologies (AIRS) stock recently?

The filing states that during the past 60 days, Aaron Rollins has not effected any transactions in Airsculpt Technologies’ common stock. His reported position therefore reflects longer-term holdings accumulated through compensation and prior open-market purchases rather than recent trading activity.

What voting power does Aaron Rollins have over Airsculpt Technologies (AIRS) shares?

Aaron Rollins reports sole voting power and sole dispositive power over 14,721,062 Airsculpt Technologies shares. He reports zero shared voting or shared dispositive power, indicating he alone can vote or decide to sell these shares, consistent with his role as a major individual shareholder.

Does the Schedule 13D mention any contracts or arrangements over Airsculpt (AIRS) securities?

The Schedule 13D states under Item 6 that there are no contracts, arrangements, understandings, or relationships with respect to Airsculpt Technologies securities. This suggests Rollins’ stake is held directly, without disclosed side agreements such as voting pacts or derivative contracts.